Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$11,165 Mln
P/E Ratio
13.01
P/B Ratio
92.18
Industry P/E
--
Debt to Equity
99.63
ROE
0.52 %
ROCE
7.69 %
Div. Yield
0 %
Book Value
1.41
EPS
10.91
CFO
$18,269.91 Mln
EBITDA
$22,956.97 Mln
Net Profit
$7,349.22 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
DaVita HealthCare Partners Inc (DVA)
| -6.68 | -7.21 | -18.04 | 5.14 | 7.80 | 13.53 | 5.22 |
|
BSE Sensex
| 1.23 | 1.57 | 3.97 | 7.26 | 11.47 | 20.39 | 11.18 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
DaVita HealthCare Partners Inc (DVA)
| 42.34 | 40.30 | -34.36 | -3.10 | 56.47 | 45.80 | -28.64 |
|
S&P Small-Cap 600
| 7.01 | 13.89 | -17.42 | 25.27 | 9.57 | 20.86 | -9.70 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 555.74 | 8,121.97 | 27.11 | 27.8 | |
| 113.37 | 11,417.38 | 25.25 | 15.7 | |
| 122.10 | 11,522.86 | 3.73 | 110.75 | |
| 171.68 | 11,194.00 | 10.2 | 17.71 |
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers... outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado. Read more
CEO & Executive Director
Mr. Javier J. Rodriguez
CEO & Executive Director
Mr. Javier J. Rodriguez
Headquarters
Denver, CO
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of DaVita HealthCare Partners Inc (DVA) stood at $ 17,285 Mln as on 31-Dec-24
The share price of DaVita HealthCare Partners Inc (DVA) is $139.56 (NYSE) as of 25-Apr-2025 16:10 EDT. DaVita HealthCare Partners Inc (DVA) has given a return of 7.8% in the last 3 years.
DaVita HealthCare Partners Inc (DVA) has a market capitalisation of $ 11,165 Mln as on 25-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/E ratio of DaVita HealthCare Partners Inc (DVA) is 13.01 times as on 25-Apr-2025.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the DaVita HealthCare Partners Inc (DVA) and enter the required number of quantities and click on buy to purchase the shares of DaVita HealthCare Partners Inc (DVA).
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
The CEO & director of Mr. Javier J. Rodriguez. is DaVita HealthCare Partners Inc (DVA), and CFO & Sr. VP is Mr. Javier J. Rodriguez.
There is no promoter pledging in DaVita HealthCare Partners Inc (DVA).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,142
|
|
|
1,052
|
|
|
1,014
|
|
|
856
|
| DaVita HealthCare Partners Inc (DVA) | Ratios |
|---|---|
|
Return on equity(%)
|
159.08
|
|
Operating margin(%)
|
15.61
|
|
Net Margin(%)
|
7.31
|
|
Dividend yield(%)
|
--
|
Yes, TTM profit after tax of DaVita HealthCare Partners Inc (DVA) was $936 Mln.
